🎉 Thrilled to share that our original article, "ABO-Incompatible Renal Transplant: A Single-Center Experience from India," from Sir Gangaram Hospital, New Delhi is featured on the cover of the current edition of the Indian Journal of Nephrology! #Nephrology #RenalTransplant

From studying under trees to leading nephrology at SGRH—Padma Shri Dr A.K. Bhalla’s inspiring path. Hear the turning points and lessons for young clinicians.

RT @AVATAROrg: Big launch at #AvatarIndia2025! .Dr Vinant Bhargava unveils his new book 'Essentials of Interventional Nephrology' 📚👨‍🏫 A mu….

RT @drpriyajohn: #AVATAR2025 debate HD VS PD in HFrEF. 👉 HD vs PD isn’t about which is superior—it’s about which fits the patient. Individu….

RT @KajareeG: 🖥️USG guided angioplasty .❓Should we do or not do?.🙄Is fluoroscopy mandatory?.Let's hear it at #AVATAR25 .🌟Wonderful conferen….

RT @AVATAROrg: Inauguration of 2nd Annual Conference - AVATAR INDIA 2025. Dr. D S Rana takes the stage at #AvatarIndia2025 Sharing insight….

Transplant immunology workshop .#AVATAR25 . Engaging discussions on cutting-edge desensitization, antibody monitoring & immune tolerance strategies are shaping the future of transplantation. #Avatar2025 .#kidneytransplant.#InAvatar25.#IntrerNeph25

RT @VinBhargava: #Avatar2025 #InAvatar25 @AVATAROrg .💥 #InterNeph25 @0900Hrs IST.💥 @tvachh .💥@maurizio .💥@BharatSachdeva.💥National Faculty….

RT @ERAkidney: 1/6.PD POV:.📊Meta-analysis of 21 studies reveals PD superiority over HD. 👵In frail, older cohorts, aPD shows higher SF-12 ph….

Population screening for Albuminuria.A Pro-Con debate.#ERA25 .#BeyondNephrology .#Nephtwitter .#MedTwitter.

Should Dialysate Sodium be high?.By Dr Manfred Hecking.#ERA25 #BeyondNephrology.

Final nail in coffin for MRAs in kidney diseases??. ACHIEVE trial at #ERA2025: Spironolactone in maintenance dialysis FAILED to reduce CV death or heart‐failure hospitalizations (HR 0.92; p 0.35) and was stopped early for futility. #ERA25 .#BeyondNephrology

BREAKTHROUGH in #IgAN care! In the Phase 3 VISIONARY study, Sibeprenlimab 400 mg delivered a staggering –50.2% reduction in 24h uPCR at 9 months vs placebo’s +2.1% (placebo-adjusted 51.2% effect; 96.5% CI 42.9-58.2%; P < 0.0001)! .#ERA25 .#BeyondNephrology

On chair - Dr A K Bhalla @drbhallaak .Dr B V Shah.#ERA25 .#BeyondNephrology.

But not without caveats 👇.⚠️ Potential for hyperkalemia, metabolic acidosis.⚠️ Safety concerns: tumor growth, cyst expansion, vascular effects. 🔍 The future? HIF-PHIs offer a more physiologic path forward—but need careful selection & monitoring.

🚨 New ERA in CKD Anemia with HFI-PHIs from – Prof. Narayan Prasad .🔹 Roxadustat boosts Hb & lowers cholesterol.🔹 Works in pre-dialysis & dialysis CKD.🔹 Stimulates endogenous EPO.🔹 Less IV iron dependency.🔹 ↓ Hepcidin = ↑ iron availability

🔥 The CONFIDENCE trial just raised the bar—combining SGLT2i + finerenone delivers a staggering >50% UACR reduction! A new standard in CKD management is here!!.#ERA25.#beyondnephrology

RT @Arunkr_Dr: #ERA25 @ConorJudge5 on Unleashing the data in free text to recognise AKI. 💻 Pre-trained models=a good start.🔧 Fine-tuning=ke….

RT @NephroSeeker: 2/ Here is part of the 🔥 team (not all them😉) #ERA25. 👇See the list here .

Just ran my kidneys off at the Renal Run by ERA 2025! 🏃‍♂️💚 Who knew nephrologists could fly?.#ERA25 .#BeyondNephrology

It takes two to tango!!.Amazing amalgamation of science and music 🎵🔬.#soundsandscience .#ERA25